Ellen de Kort

15 General introduction 1 39. Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr 2011;23:167-172. 40. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm, et al. For the Danish- Swedish multicenter study group. Surfactant therapy and nasal continuous airway pressure for newborns with respiratory distress syndrome. NJEM 1994;133:1051-1055. 41. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation versus selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007;4:ID CD003063. 42. Vento M, Bohlin K, Herting E, Roehr CC, Dargaville P. Surfactant administration via thin catheter: a practical guide. Neonatology 2019;116:211-216. 43. Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneously breathing with nCPAP: feasibility and outcome in extremely preterm infants (postmenstrual age ≤ 27 weeks). Pediatr Anesth 2007;17:364-369. 44. Dargaville P, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin COF, Carlin JB, et al. Minimally- invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed 2013;98:F122-126. 45. Aldana Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2017;102:F17-23. 46. Isayama T, Iwmai J, McDonald S, Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants. JAMA 2016;316:611-624. 47. Rigo V, Lefebvre C, Broux I. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis. Eur J Pediatr 2016;175:1933-1942. 48. Gortner L, Schüller SS, Herting E. Review demonstrates that less invasive surfactant administration in preterm neonates leads to fewer complications. Acta Paediatr 2018;107:736- 734. 49. GöpelW, KribsA, ZieglerA, Laux R, HoehnT,Wieg C et al.; German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomized, controlled trial. Lancet 2011;378:1627-1634. 50. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013;131:e502- 509. 51. Kribs A, Roll C, Göpel W, Wieg C, Groneck P, Laux R, et al. For the NINSAPP Trial Investigators. Nonintubated surfactant application vs conventional therapy in extremely preterm infants. A randomized controlled trial. JAMA Pediatr 2015;169:723-730. 52. Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration – a survey. Eur J Pediatr 2017:176:147-154. 53. Jeffreys E, Hunt K, Dassios T, Greenough A. UK survey of less invasive surfactant administration. Arch Dis Child Fetal Neonatal Ed 2019;0:F1. 54. Kurepa D, Perveen S, Lipener Y, Kakkilaya V. The use of less invasive surfactant administration (LISA) in the united states with review of the literature. J Perinatol 2019;39:426-432. 55. Heiring C, Jonsson B, Andersson S, Björklund L. Survey shows large differences between the Nordic countries in the use of less invasive surfactant administration. Acta Paediatr 2016;106:382- 386. 56. Bhayat S, Kaur A, Premadeva I, Reynolds P, Gowda H. Survey of less invasive surfactant administration in England, slow adoption and variable practice. Acta Paediatr 2019;00:1-6.